Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Colorectal Cancer
Interventions
DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

semaxanib

Trial Locations (26)

10595

New York Medical College, Valhalla

18510

Hematology/Oncology Associates of NE Pennsylvania, P.C., Scranton

21231

Johns Hopkins Oncology Center, Baltimore

27609

Raleigh Hematology/Oncology Associates - Wake Practice, Raleigh

33428

Comprehensive Cancer Care Specialists of Boca Raton, Boca Raton

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

37205

Dial Research Associates, Inc., Nashville

37404

Associates in Oncology & Hematology, Chattanooga

48824

Michigan State University, East Lansing

53792

University of Wisconsin Comprehensive Cancer Center, Madison

55455

University of Minnesota Cancer Center, Minneapolis

70809

Mary Bird Perkins Cancer Center, Baton Rouge

75231

Presbyterian Hospital of Dallas, Dallas

90048

Tower Hematology Oncology Medical Group, Los Angeles

92037

Scripps Clinic, La Jolla

94109

St. Francis Hospital, San Francisco

96813

Queen's Medical Center, Honolulu

36106-2801

Alabama Oncology, LLC, Montgomery

91007-7678

Office of Richard Shapiro, Benjamin Stafford, and Sharon J. Yee, Arcadia

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

02120

Cancer Center of Boston, Boston

07024

APN-IMPATH Research Corporation, Fort Lee

07601

Hackensack University Medical Center, Hackensack

28233-3549

Presbyterian Healthcare, Charlotte

77555-0209

University of Texas Medical Branch, Galveston

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY